相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro
Javier Milara et al.
SCIENTIFIC REPORTS (2022)
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease A Randomized, Double-Blind, Multicenter, Parallel-Group Study
Fernando J. Martinez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Triple therapy in uncontrolled asthma: a network meta-analysis of phase III studies
Paola Rogliani et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Comparisons of Efficacy and Safety between Triple (Inhaled Corticosteroid/Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist) Therapies in Chronic Obstructive Pulmonary Disease: Systematic Review and Bayesian Network Meta-Analysis
Hyun Woo Lee et al.
RESPIRATION (2021)
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
PLOS MEDICINE (2021)
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD
Sandeep Bansal et al.
NPJ PRIMARY CARE RESPIRATORY MEDICINE (2021)
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial
Jinping Zheng et al.
RESPIRATORY RESEARCH (2021)
Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo
Paola Rogliani et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
David A. Lipson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD
Klaus F. Rabe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
Gary T. Ferguson et al.
RESPIRATORY RESEARCH (2020)
RoB 2: a revised tool for assessing risk of bias in randomised trials
Jonathan A. C. Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Comparisons of exacerbations and mortality among regular inhaled therapies for patients with stable chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis
Hyun Woo Lee et al.
PLOS MEDICINE (2019)
Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial
Kenneth R. Chapman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
David A. Lipson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Inhaled corticosteroids in COPD: friend or foe?
Alvar Agusti et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
Yayuan Zheng et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
The Cholinergic Pathways in Inflammation: A Potential Pharmacotherapeutic Target for COPD
Mitsuhiro Yamada et al.
FRONTIERS IN PHARMACOLOGY (2018)
The dose of inhaled corticosteroids in patients with COPD: when less is better
Jose Luis Izquierdo et al.
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)
Efficacy and safety of tiotropium bromide combined with budesonide/formoterol in the treatment of moderate to severe chronic obstructive pulmonary disease
Daguo Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Severe and Difficult-to-Treat Asthma in Adults
Elliot Israel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease
David A. Lipson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies
Thomas M. Siler et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2016)
Efficacy and tolerability of budesonide/formoterol added to tiotropium compared with tiotropium alone in patients with severe or very severe COPD: A randomized, multicentre study in East Asia
Sang-Do Lee et al.
RESPIROLOGY (2016)
Understanding how long-acting β2-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids in asthma - an update
Robert Newton et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
Jessie McGowan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial
Jorgen Vestbo et al.
LANCET (2016)
Interaction between corticosteroids and muscarinic antagonists in human airways
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2016)
Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation
L. Dejager et al.
MUCOSAL IMMUNOLOGY (2015)
Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: Results of two randomized studies
Thomas M. Siler et al.
RESPIRATORY MEDICINE (2015)
Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN studya randomised controlled trial
Peter A. Frith et al.
THORAX (2015)
Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT)
Alex J. Mackay et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Kian Fan Chung et al.
EUROPEAN RESPIRATORY JOURNAL (2014)
Withdrawal of Inhaled Glucocorticoids and Exacerbations of COPD
Helgo Magnussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Recovering the raw data behind a non-parametric survival curve
Zhihui Liu et al.
SYSTEMATIC REVIEWS (2014)
Risk of hospital admission or emergency room visit for pneumonia in patients using respiratory inhalers: A case-crossover study
Chang-Hoon Lee et al.
RESPIROLOGY (2013)
Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: A randomized controlled study
Ki Suck Jung et al.
RESPIRATORY MEDICINE (2012)
Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
Nicola A. Hanania et al.
RESPIRATORY MEDICINE (2012)
Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool
Georgia Salanti
RESEARCH SYNTHESIS METHODS (2012)
Inhaled Corticosteroids and Risk of Tuberculosis in Patients with Respiratory Diseases
Paul Brassard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies
Yoon K. Loke et al.
THORAX (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression
Samy Suissa et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD
Y. K. Loke et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Checking consistency in mixed treatment comparison meta-analysis
S. Dias et al.
STATISTICS IN MEDICINE (2010)
Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: a Bayesian meta-analytic perspective
John L. Moran et al.
CRITICAL CARE (2010)
Efficacy and Tolerability of Budesonide/Formoterol Added to Tiotropium in Patients with Chronic Obstructive Pulmonary Disease
Tobias Welte et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results
C. Crim et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease - Results from the TORCH study
Bartolome R. Celli et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Inhaled Corticosteroids in Patients With Stable Chronic Obstructive Pulmonary Disease A Systematic Review and Meta-analysis
M. Bradley Drummond et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Bayesian meta-analysis of multiple treatment comparisons: An introduction to mixed treatment comparisons
Jeroen P. Jansen et al.
VALUE IN HEALTH (2008)
Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia
Pierre Ernst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial
Shawn D. Aaron et al.
ANNALS OF INTERNAL MEDICINE (2007)
Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease
Peter M. A. Calverley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD
Mario Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2007)
Mortality in COPD: role of comorbidities
D. D. Sin et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Advances in asthma and COPD treatment: Combination therapy with inhaled corticosteroids and long-acting beta(2)-agonists
A. Miller-Larsson et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease
JR Hurst et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients
D Ozol et al.
RESPIRATORY MEDICINE (2005)
Decreased histone deacetylase activity in chronic obstructive pulmonary disease
K Ito et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis
M Masoli et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
The nature of small-airway obstruction in chronic obstructive pulmonary disease
JC Hogg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Combination of direct and indirect evidence in mixed treatment comparisons
G Lu et al.
STATISTICS IN MEDICINE (2004)
Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD
RA O'Donnell et al.
THORAX (2004)
A population based case-control study of cataract and inhaled corticosteroids
L Smeeth et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
COPD exacerbations: definitions and classifications
S Burge et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
PS Burge et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
分享论文
